Want to see HK:1833 full AI Analyst Report?
1833 Stock Chart & Stats
HK$7.38
HK$0.15(2.03%)
At close: 4:00 PM EDT
HK$7.38
HK$0.15(2.03%)
Day’s Range― - ―
52-Week RangeHK$6.57 - HK$24.40
Previous CloseN/A
Volume6.53M
Average Volume (3M)17.30M
Market Cap
HK$16.90B
Enterprise ValueHK$22.21K
Total Cash (Recent Filing)HK$6.97B
Total Debt (Recent Filing)HK$39.81M
Price to Earnings (P/E)37.9
Beta1.42
Next Earnings
Aug 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.18
Shares Outstanding2,161,443,600
10 Day Avg. Volume8,945,339
30 Day Avg. Volume17,297,252
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)2.69
Price to Sales (P/S)4.88
P/FCF Ratio68.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$16.10Price Target Upside118.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.22
Revenue Forecast (FY)HK$5.73B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low leverage (debt-to-equity ~0.4% in 2025) materially reduces financial risk and preserves strategic optionality. A conservative capital structure supports investments in product and enterprise sales, lets management absorb cyclical shocks, and makes funding for growth less dilutive.
Return To ProfitabilityReversing multi-year losses to post positive net income in 2024 and stronger profitability in 2025 signals improving unit economics and operating leverage. Sustained profits provide internal capital for reinvestment, strengthen governance incentives, and reduce reliance on external financing over the medium term.
Strengthening Free Cash FlowFCF turning positive and strengthening in 2025, with FCF near net income, supports earnings quality and funding for R&D and platform expansion. Durable cash generation enhances balance-sheet flexibility, enables organic growth investments, and reduces short-term liquidity pressure.
Bears Say
Top-line VolatilityThe uneven revenue trajectory—sharp contraction in 2022–2023 with only modest growth in 2024 before a 2025 rebound—undermines revenue predictability. Persistent top-line volatility complicates capacity planning, makes margin sustainability dependent on retention and monetization, and raises execution risk.
Year-to-year Equity SwingsNotable swings in reported equity, particularly the lower 2024 level, suggest accounting adjustments, capital changes, or one-offs that hinder trend analysis. This increases interpretive risk about the true capital base and complicates assessment of long-term leverage and solvency metrics.
Uneven Cash ConversionAlthough FCF turned positive, cash conversion has been inconsistent and operating cash flow coverage is still relatively low. Sensitivity to working-capital swings can constrain investment cadence, expose liquidity to operational seasonality, and requires monitoring to confirm durable free cash flow margins.
Ping An Healthcare and Technology Company News
1833 FAQ
What was Ping An Healthcare and Technology Company Limited’s price range in the past 12 months?
Ping An Healthcare and Technology Company Limited lowest stock price was HK$6.57 and its highest was HK$24.40 in the past 12 months.
What is Ping An Healthcare and Technology Company Limited’s market cap?
Ping An Healthcare and Technology Company Limited’s market cap is HK$16.90B.
When is Ping An Healthcare and Technology Company Limited’s upcoming earnings report date?
Ping An Healthcare and Technology Company Limited’s upcoming earnings report date is Aug 18, 2026 which is in 11 days.
How were Ping An Healthcare and Technology Company Limited’s earnings last quarter?
Currently, no data Available
Is Ping An Healthcare and Technology Company Limited overvalued?
According to Wall Street analysts Ping An Healthcare and Technology Company Limited’s price is currently Undervalued.
Does Ping An Healthcare and Technology Company Limited pay dividends?
Ping An Healthcare and Technology Company Limited pays a Notavailable dividend of HK$9.7 which represents an annual dividend yield of N/A. See more information on Ping An Healthcare and Technology Company Limited dividends here
What is Ping An Healthcare and Technology Company Limited’s EPS estimate?
Ping An Healthcare and Technology Company Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ping An Healthcare and Technology Company Limited have?
Ping An Healthcare and Technology Company Limited has 2,161,443,600 shares outstanding.
What happened to Ping An Healthcare and Technology Company Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ping An Healthcare and Technology Company Limited?
Currently, no hedge funds are holding shares in HK:1833
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ping An Healthcare and Technology Company Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
1135.06%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-17.64%
Trailing 12-Months
Company Description
Ping An Healthcare and Technology Company Limited
Ping An Healthcare and Technology Company Limited (PAHT), through its subsidiaries, operates a comprehensive online platform that delivers healthcare services across the People's Republic of China. Its core offerings encompass virtual medical consultations, facilitated hospital referrals and appointment scheduling, inpatient care coordination, and expert second opinions. PAHT also provides standardized consumer healthcare packages, integrating services from a network of medical institutions. Beyond services, the company offers a broad array of products, including pharmaceuticals, health supplements, medical devices, wellness items such as fitness equipment and personal care products, and other miscellaneous goods. Furthermore, PAHT engages users with health management and wellness interaction services, featuring various programs, interactive tools, activities, and personalized content. Its additional operations include medicine marketing, technology services, application development and maintenance, direct hospital and clinic services, and the management of an insurance agency. Established in 2014, Ping An Healthcare and Technology Company Limited maintains its headquarters in Shanghai, China.
1833 Stock 12 Month Forecast
Average Price Target
HK$16.10
▲(118.16% Upside)
Technical Analysis
Dingdang Health Technology Group Ltd.
―
Perfect Medical Health Management Limited
―
Yidu Tech, Inc.
―
Medlive Technology Co., Ltd.
―
Xunfei Healthcare Technology Co., Ltd.
―